Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.95 | 8.79 | 11.12 | 10.74 | 9.26 | 10.38 | 11.40 | 11.24 | 11.12 | 10.82 | 12.82 | 12.06 |
| Expenses | 5.84 | 6.55 | 7.63 | 7.91 | 6.90 | 7.84 | 7.90 | 8.34 | 8.19 | 8.16 | 9.18 | 8.78 |
| Operating Profit | 2.11 | 2.24 | 3.49 | 2.83 | 2.36 | 2.54 | 3.50 | 2.90 | 2.93 | 2.66 | 3.64 | 3.28 |
| OPM % | 26.54% | 25.48% | 31.38% | 26.35% | 25.49% | 24.47% | 30.70% | 25.80% | 26.35% | 24.58% | 28.39% | 27.20% |
| Other Income | 0.05 | 0.00 | 0.06 | 0.01 | 0.01 | 0.01 | 0.04 | 0.00 | 0.01 | 0.89 | 0.06 | 0.02 |
| Interest | 0.74 | 0.67 | 0.77 | 0.72 | 0.66 | 0.69 | 0.58 | 0.60 | 0.69 | 0.81 | 0.71 | 0.73 |
| Depreciation | 1.41 | 1.43 | 1.49 | 1.50 | 1.61 | 1.68 | 1.70 | 1.68 | 1.69 | 1.83 | 1.89 | 1.97 |
| Profit before tax | 0.01 | 0.14 | 1.29 | 0.62 | 0.10 | 0.18 | 1.26 | 0.62 | 0.56 | 0.91 | 1.10 | 0.60 |
| Tax % | 0.00% | 57.14% | 46.51% | 30.65% | 20.00% | 44.44% | 26.98% | 38.71% | 57.14% | 64.84% | 6.36% | 3.33% |
| Net Profit | 0.01 | 0.06 | 0.68 | 0.42 | 0.08 | 0.11 | 0.92 | 0.39 | 0.24 | 0.31 | 1.03 | 0.58 |
| EPS in Rs | 0.01 | 0.09 | 0.98 | 0.60 | 0.11 | 0.16 | 1.32 | 0.56 | 0.34 | 0.45 | 1.48 | 0.83 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.10 | 28.63 | 30.40 | 33.74 | 28.16 | 25.69 | 30.04 | 34.44 | 36.70 | 41.78 | 46.01 | 46.82 |
| Expenses | 19.95 | 23.85 | 24.06 | 26.48 | 24.62 | 21.57 | 21.14 | 24.17 | 26.42 | 30.48 | 33.83 | 34.31 |
| Operating Profit | 5.15 | 4.78 | 6.34 | 7.26 | 3.54 | 4.12 | 8.90 | 10.27 | 10.28 | 11.30 | 12.18 | 12.51 |
| OPM % | 20.52% | 16.70% | 20.86% | 21.52% | 12.57% | 16.04% | 29.63% | 29.82% | 28.01% | 27.05% | 26.47% | 26.72% |
| Other Income | -0.05 | 0.86 | 0.35 | 0.25 | -2.80 | 0.49 | 0.12 | 2.47 | 0.16 | 0.07 | 0.96 | 0.98 |
| Interest | 1.23 | 1.47 | 1.59 | 1.54 | 1.89 | 2.82 | 3.23 | 3.52 | 3.06 | 2.72 | 2.86 | 2.94 |
| Depreciation | 2.73 | 2.86 | 3.16 | 3.68 | 4.56 | 4.60 | 5.43 | 5.50 | 5.71 | 6.50 | 7.09 | 7.38 |
| Profit before tax | 1.14 | 1.31 | 1.94 | 2.29 | -5.71 | -2.81 | 0.36 | 3.72 | 1.67 | 2.15 | 3.19 | 3.17 |
| Tax % | 36.84% | 32.06% | 29.90% | 30.13% | -32.05% | -7.12% | 44.44% | 13.71% | 32.93% | 29.30% | 38.56% | |
| Net Profit | 0.72 | 0.89 | 1.35 | 1.60 | -3.88 | -2.61 | 0.21 | 3.21 | 1.11 | 1.52 | 1.96 | 2.16 |
| EPS in Rs | 1.03 | 1.28 | 1.94 | 2.30 | -5.57 | -3.75 | 0.30 | 4.61 | 1.59 | 2.18 | 2.81 | 3.10 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 6% | 12% | 10% | 11% | ||
| Compounded Profit Growth | 3% | 19% | -14% | 27% | ||
| Stock Price CAGR | 30% | 56% | 47% | -2% | ||
| Return on Equity | 3% | 5% | 5% | 4% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 |
| Reserves | 12.35 | 13.07 | 14.16 | 15.43 | 17.04 | 13.26 | 10.78 | 10.94 | 14.14 | 15.25 | 16.64 | 18.61 |
| Borrowings | 11.65 | 13.68 | 11.20 | 12.43 | 17.05 | 31.64 | 39.15 | 37.29 | 32.41 | 30.87 | 29.15 | 34.17 |
| Other Liabilities | 6.70 | 8.81 | 8.32 | 9.85 | 14.28 | 13.14 | 9.48 | 9.22 | 6.84 | 8.86 | 12.57 | 12.17 |
| Total Liabilities | 37.67 | 42.53 | 40.65 | 44.68 | 55.34 | 65.01 | 66.38 | 64.42 | 60.36 | 61.95 | 65.33 | 71.92 |
| Fixed Assets | 19.28 | 17.64 | 22.23 | 28.62 | 34.81 | 33.08 | 50.32 | 46.56 | 44.83 | 43.43 | 47.61 | 51.55 |
| CWIP | 2.73 | 8.99 | 4.28 | 0.00 | 3.23 | 13.06 | 0.50 | 1.67 | 0.31 | 2.99 | 0.00 | 0.40 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 15.66 | 15.90 | 14.14 | 16.06 | 17.30 | 18.87 | 15.56 | 16.19 | 15.22 | 15.53 | 17.72 | 19.97 |
| Total Assets | 37.67 | 42.53 | 40.65 | 44.68 | 55.34 | 65.01 | 66.38 | 64.42 | 60.36 | 61.95 | 65.33 | 71.92 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2.30 | 0.01 | 6.57 | 6.25 | 6.91 | 2.87 | 5.90 | 7.88 | 8.25 | 11.55 | 11.78 | 7.86 |
| Cash from Investing Activity | -0.73 | -0.01 | -1.88 | -4.92 | -9.76 | -13.76 | -7.65 | -2.71 | -0.71 | -6.65 | -7.61 | -7.07 |
| Cash from Financing Activity | -1.37 | 0.00 | -4.89 | -0.94 | 2.13 | 11.09 | 1.63 | -5.07 | -7.61 | -4.58 | -4.22 | -1.20 |
| Net Cash Flow | 0.21 | 0.00 | -0.20 | 0.39 | -0.72 | 0.20 | -0.12 | 0.10 | -0.07 | 0.32 | -0.04 | -0.41 |
| Free Cash Flow | 1.40 | 0.00 | 4.18 | 1.30 | -3.09 | -11.18 | -2.18 | 5.05 | 7.34 | 4.54 | 4.09 | 0.62 |
| CFO/OP | 53% | 0% | 124% | 124% | 137% | 111% | 68% | 75% | 73% | 117% | 122% | 69% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 126.15 | 124.77 | 112.19 | 118.62 | 95.09 | 90.60 | 115.94 | 125.03 | 112.87 | 103.33 | 98.46 | 116.85 |
| Inventory Days | 0.00 | 0.00 | 28.27 | 30.50 | 37.89 | 20.28 | 15.62 | 46.09 | 34.68 | 51.33 | 65.94 | 25.47 |
| Days Payable | 591.13 | 594.31 | 660.70 | 723.24 | 685.97 | 741.06 | 297.29 | 560.33 | 639.34 | 594.19 | ||
| Cash Conversion Cycle | 126.15 | 124.77 | -450.67 | -445.18 | -527.72 | -612.36 | -554.41 | -569.95 | -149.73 | -405.67 | -474.95 | -451.87 |
| Working Capital Days | 29.26 | 3.34 | -23.71 | -18.37 | 28.02 | 21.13 | -49.73 | -23.33 | 11.66 | -49.13 | -71.29 | -35.14 |
| ROCE % | 7.94% | 7.51% | 7.33% | 10.51% | 10.09% | -1.48% | 0.00% | 6.40% | 9.16% | 8.87% | 9.20% | 9.44% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.94% | 4.31% | 5.69% | 5.69% | 6.03% | 7.02% |
| Public | 68.52% | 68.52% | 68.52% | 68.53% | 68.52% | 68.52% | 66.58% | 64.22% | 62.83% | 62.83% | 62.49% | 61.49% |
| No. of Shareholders | 3,777 | 3,909 | 4,187 | 4,051 | 4,334 | 4,466 | 4,162 | 4,167 | 4,067 | 4,057 | 4,011 | 3,945 |
Fundamentals
Market Cap₹ 132 Cr.
Current Price₹ 189
Stock P/E69.2
Book Value₹ 36.7
ROCE9.44 %
ROE4.19 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)11%
Compounded Profit Growth (TTM)27%
Standalone figures.
Valuation
Market capRs 126 Cr
Enterprise valueRs 160 Cr
P/E (TTM)58.43x
Price to book4.93x
Price to sales2.70x
EV / EBITDA11.87x
EV / EBIT26.21x
EV / sales3.42x
Price to cash flow16.06x
Earnings yield1.71%
P/E, 3-year average39.49x
P/B, 3-year average2.56x
P/E, 5-year average41.99x
P/B, 5-year average1.96x
Profitability
Operating margin (excl. other income)26.47%
Operating margin (incl. other income)28.56%
EBITDA margin28.81%
Pre-tax margin6.77%
Net profit margin4.61%
Net margin, latest quarter4.81%
ROE7.97%
ROCE10.75%
ROA2.86%
ROE, 3-year average6.58%
ROCE, 3-year average9.61%
ROA, 3-year average2.35%
ROE, 5-year average7.47%
ROCE, 5-year average9.71%
ROA, 5-year average2.51%
ROIC (approx.)6.31%
Tax rate38.56%
Other income / net worth3.75%
Growth
Sales growth (latest year)10.12%
Profit growth (latest year)28.95%
Sales CAGR, 3 years10.14%
Sales CAGR, 5 years12.36%
Profit CAGR, 3 years-15.16%
Sales growth QoQ-5.93%
Profit growth QoQ-43.69%
Sales growth YoY (latest quarter)7.30%
Profit growth YoY (latest quarter)48.72%
Per share
EPS (TTM)Rs 3.10
EPS (latest year)Rs 2.81
EPS (latest quarter)Rs 0.83
EPS, 3-year averageRs 2.20
EPS, 5-year averageRs 2.30
Book value per shareRs 36.73
Sales per shareRs 67.22
Cash flow per shareRs 11.29
Free cash flow per shareRs 0.89
Efficiency
Asset turnover0.64x
Fixed asset turnover0.89x
Inventory turnover35.96x
Inventory days10 days
Debtor days117 days
Debtors turnover3.12x
Creditor days594 days
Cash conversion cycle-452 days
Working capital days-35 days
Leverage
Total debtRs 34 Cr
Cash and bankRs 0 Cr
Net debtRs 34 Cr
Debt to equity1.34x
Net debt / EBITDA2.52x
Interest coverage2.08x
Owners' fund to total sources35.57%
Debt to assets47.51%
Cash flow
Cash from Operating Activity (latest year)Rs 8 Cr
Cash from Investing Activity (latest year)Rs -7 Cr
Cash from Financing Activity (latest year)Rs -1 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 6 Cr
Cash from ops / profit, 5 years5.91x
Sales to cash flow5.85x
Statement figures
Net sales (TTM)Rs 47 Cr
Net sales (latest year)Rs 46 Cr
Sales (latest quarter)Rs 12 Cr
Operating profit excl. other income (latest year)Rs 12 Cr
Operating profit (latest quarter)Rs 3 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 13 Cr
PBDT (TTM)Rs 11 Cr
Profit before tax (TTM)Rs 3 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 2 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs 1 Cr
Depreciation (TTM)Rs 7 Cr
Depreciation (latest quarter)Rs 2 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 9 Cr
Total expenditure (latest year)Rs 34 Cr
Total income (latest year)Rs 47 Cr
Share capitalRs 7 Cr
ReservesRs 19 Cr
Shareholders' fundsRs 26 Cr
Total assetsRs 72 Cr
Net blockRs 52 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 15 Cr
InventoryRs 0 Cr
Other liabilitiesRs 12 Cr
Shares outstanding (crore)0.70
Ownership
Promoter holding31.48% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 58.4 is at the 74th percentile of its own 7.4-year range
(median 21.2, low 3.7, high 141.6).
P/B 4.93 is at the 95th percentile (median 1.05).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 526546 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -8.9% | -2.8% | -6.2 pts |
| 1 month | +20.4% | -6.8% | +27.2 pts |
| 3 months | +52.9% | -7.6% | +60.5 pts |
| 3 years | +204.8% | +14.2% | +190.6 pts |
| 5 years | +752.7% | +27.9% | +724.8 pts |
Red flags
F-score 6 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹12 Cr +7.3% vs Jun 2025.
Net profit ₹1 Cr +48.7%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Star Imaging and Path Lab Ltd | 131 | 6.80 | 26.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Choksi Laboratories Ltd?
Choksi Laboratories Ltd (526546) has a market capitalisation of Rs 132 Cr. at the 2026-10-01 close.
What is the P/E ratio of Choksi Laboratories Ltd?
Choksi Laboratories Ltd trades at a P/E of 69.2 on trailing twelve-month profit, at the 2026-10-01 close.
What were Choksi Laboratories Ltd's latest quarterly results?
In the Jun 2026 quarter, Choksi Laboratories Ltd sales was Rs 12 Cr (+7.3% vs Jun 2025) and net profit was Rs 1 Cr.